Skip to main content
Top
Published in: Cancer Cell International 1/2018

Open Access 01-12-2018 | Primary research

Carnosine selectively inhibits migration of IDH-wildtype glioblastoma cells in a co-culture model with fibroblasts

Authors: Henry Oppermann, Johannes Dietterle, Katharina Purcz, Markus Morawski, Christian Eisenlöffel, Wolf Müller, Jürgen Meixensberger, Frank Gaunitz

Published in: Cancer Cell International | Issue 1/2018

Login to get access

Abstract

Background

Glioblastoma (GBM) is a tumor of the central nervous system. After surgical removal and standard therapy, recurrence of tumors is observed within 6–9 months because of the high migratory behavior and the infiltrative growth of cells. Here, we investigated whether carnosine (β-alanine-l-histidine), which has an inhibitory effect on glioblastoma proliferation, may on the opposite promote invasion as proposed by the so-called “go-or-grow concept”.

Methods

Cell viability of nine patient derived primary (isocitrate dehydrogenase wildtype; IDH1R132H non mutant) glioblastoma cell cultures and of eleven patient derived fibroblast cultures was determined by measuring ATP in cell lysates and dehydrogenase activity after incubation with 0, 50 or 75 mM carnosine for 48 h. Using the glioblastoma cell line T98G, patient derived glioblastoma cells and fibroblasts, a co-culture model was developed using 12 well plates and cloning rings, placing glioblastoma cells inside and fibroblasts outside the ring. After cultivation in the presence of carnosine, the number of colonies and the size of the tumor cell occupied area were determined.

Results

In 48 h single cultures of fibroblasts and tumor cells, 50 and 75 mM carnosine reduced ATP in cell lysates and dehydrogenase activity when compared to the corresponding untreated control cells. Co-culture experiments revealed that after 4 week exposure to carnosine the number of T98G tumor cell colonies within the fibroblast layer and the area occupied by tumor cells was reduced with increasing concentrations of carnosine. Although primary cultured tumor cells did not form colonies in the absence of carnosine, they were eliminated from the co-culture by cell death and did not build colonies under the influence of carnosine, whereas fibroblasts survived and were healthy.

Conclusions

Our results demonstrate that the anti-proliferative effect of carnosine is not accompanied by an induction of cell migration. Instead, the dipeptide is able to prevent colony formation and selectively eliminates tumor cells in a co-culture with fibroblasts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon: International Agency for Research on Cancer; 2016. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon: International Agency for Research on Cancer; 2016.
5.
go back to reference Gulewitsch W, Amiradzibi S. Ueber das Carnosin, eine neue organische Base des Fleischextraktes. Ber Dtsch Chem Ges. 1900;33:1902–3.CrossRef Gulewitsch W, Amiradzibi S. Ueber das Carnosin, eine neue organische Base des Fleischextraktes. Ber Dtsch Chem Ges. 1900;33:1902–3.CrossRef
8.
go back to reference Hipkiss AR, Gaunitz F. Inhibition of tumour cell growth by carnosine: some possible mechanisms. Amino Acids. 2014;46:327–37.CrossRefPubMed Hipkiss AR, Gaunitz F. Inhibition of tumour cell growth by carnosine: some possible mechanisms. Amino Acids. 2014;46:327–37.CrossRefPubMed
9.
go back to reference Nagai K, Suda T. Antineoplastic effects of carnosine and beta-alanine—physiological considerations of its antineoplastic effects. J Physiol Soc Jpn. 1986;48:741–7. Nagai K, Suda T. Antineoplastic effects of carnosine and beta-alanine—physiological considerations of its antineoplastic effects. J Physiol Soc Jpn. 1986;48:741–7.
10.
14.
go back to reference Gaunitz F, Oppermann H, Hipkiss AR. Carnosine and cancer. In: Preedy VR, editor. Imidazole dipeptides. Cambridge: The Royal Society of Chemistry; 2015. p. 372–92.CrossRef Gaunitz F, Oppermann H, Hipkiss AR. Carnosine and cancer. In: Preedy VR, editor. Imidazole dipeptides. Cambridge: The Royal Society of Chemistry; 2015. p. 372–92.CrossRef
19.
go back to reference Holliday R, McFarland GA. A role for carnosine in cellular maintenance. Biochemistry (Mosc). 2000;65:843–8. Holliday R, McFarland GA. A role for carnosine in cellular maintenance. Biochemistry (Mosc). 2000;65:843–8.
21.
go back to reference McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide l-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999;34:35–45.CrossRefPubMed McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide l-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999;34:35–45.CrossRefPubMed
22.
go back to reference Hainfellner JA, Voigtländer T, Ströbel T, Mazal PR, Maddalena AS, Aguzzi A, Budka H. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol. 2001;60:449–61.CrossRefPubMed Hainfellner JA, Voigtländer T, Ströbel T, Mazal PR, Maddalena AS, Aguzzi A, Budka H. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol. 2001;60:449–61.CrossRefPubMed
Metadata
Title
Carnosine selectively inhibits migration of IDH-wildtype glioblastoma cells in a co-culture model with fibroblasts
Authors
Henry Oppermann
Johannes Dietterle
Katharina Purcz
Markus Morawski
Christian Eisenlöffel
Wolf Müller
Jürgen Meixensberger
Frank Gaunitz
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2018
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-018-0611-2

Other articles of this Issue 1/2018

Cancer Cell International 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine